2. As of noon trading, Abbott Laboratories ( ABT) is up $0.33 (1.0%) to $35.03 on light volume Thus far, 4.5 million shares of Abbott Laboratories exchanged hands as compared to its average daily volume of 14.2 million shares. The stock has ranged in price between $34.78-$35.10 after having opened the day at $34.84 as compared to the previous trading day's close of $34.70. Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Abbott Laboratories has a market cap of $54.5 billion and is part of the health services industry. The company has a P/E ratio of 6.8, below the S&P 500 P/E ratio of 17.7. Shares are up 5.2% year to date as of the close of trading on Thursday. Currently there are 8 analysts that rate Abbott Laboratories a buy, no analysts rate it a sell, and 10 rate it a hold. TheStreet Ratings rates Abbott Laboratories as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, a generally disappointing performance in the stock itself and feeble growth in the company's earnings per share. Get the full Abbott Laboratories Ratings Report now. It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE
Ikaria, which focuses on therapies for critically ill infants, is privately owned by a group led by Madison Dearborn Partners. Buyer Mallinckrodt specializes in diagnostic radiology and pain management.